Connect with us

Futures Resume Levitation, Push On To New All Time Highs

Futures Resume Levitation, Push On To New All Time Highs

One day after a brief interruption in the Santa rally, as US stocks fell for the first time in five days amid a rotation out of megacap tech shares, futures have resumed their upward…

Published

on

Futures Resume Levitation, Push On To New All Time Highs

One day after a brief interruption in the Santa rally, as US stocks fell for the first time in five days amid a rotation out of megacap tech shares, futures have resumed their upward climb as investors brushed aside rapidly shifting fears about the economic implications of the omicron coronavirus outbreak. Treasury yields ticked higher along with the dollar. Bitcoin continued its recent tax-loss related selling which pushed it back under $47,000. As of 730am ET, emini S&P futures were up 2 points or 0.04%, fading an earlier gain which pushed ES up to 4,790, while Dow Jones futures were flat and Nasdaq futures were up 0.16%.

Tesla gained more than 2% in pre-market trading after Elon Musk sold a further $1.02 billion off shares, taking him that much closer to his target of reducing his stake in the electric-car maker by 10%. Other notable premarket movers include:

  • Shares in Apple (AAPL US) rise 0.2% in premarket trading after it closed lower on Tuesday after a four-day rally that put it within striking distance of a historic $3 trillion market value
  • Calix (CALX US) climbed 8.9% in extended trading on news the software company will join the S&P Midcap 400 Index before trading opens on Jan. 4
  • Chembio Diagnostics (CEMI US) sank 22% postmarket after saying the FDA declined to review the company’s application for an emergency use authorization (EUA) for its DPP Respiratory Antigen Panel -- a test for coronavirus and influenza
  • Cal-Maine Foods Inc. (CALM US) fell 7.1% in after- hours trading as the egg producer posted 2Q profit that missed the average analyst estimate

Shares slipped in Japan, technology stocks drove a retreat in Hong Kong and China slid (more below). Sentiment in China is being sapped by Beijing’s tightening oversight of overseas share sales and economic risks from a property slowdown. Authorities are expected to add stimulus next year to steady expansion.

In the latest Omicron news, two years after reports of the mysterious disease first emerged in Wuhan, the pandemic shows no signs of abating, with the omicron variant pushing worldwide Covid-19 cases above 1 million for a second straight day. The Netherlands will require travelers arriving from the U.S. to self-quarantine for up to ten days. Rapid tests that are widely used to detect infections may miss some omicron cases, according to the U.S. Food and Drug Administration. Covid hospitalizations are spiking from New South Wales to New York state, pressuring health systems. Overall, however, omicron appears to be triggering a lower rate of hospitalizations. In China’s Xi’an, an outbreak eased after residents were asked to stay indoors and driving was banned.

“Although omicron cases in the U.S. and Europe amongst others, continue to surge, it has yet to make its presence felt negatively in economic data,” Jeffrey Halley, a senior market analyst at Oanda, said in a note. “With market activity much reduced for the holiday season, investors continue to tentatively price in a global recovery hitting a minor bump, and not a pothole.”

As Bloomberg notes, investors are rounding out the year by booking profits after a 17% jump in global equities. The coronavirus, Federal Reserve policy tightening and China’s outlook are cited among the key risks for 2022. Omicron fears are easing on growing evidence that the fast-spreading strain leads to milder symptoms. Still volatility remains with the Nasdaq now swinging more than 2.5% per week for 5 consecutive weeks, the longest stretch in a decade.

“We’re sober about potential headwinds that still could be coming, even the rest of this year, but early in 2022 -- the Fed is going to be raising rates, that will change things for the markets,” Ann Miletti, head of active equity at Allspring Global Investments, said on Bloomberg Television. “We are also hopeful because as you look at a lot of the economic data, it remains strong.”

In Europe, the Stoxx Europe 600 index hit a new all-time high record before retreating, with retailers outperforming. The FTSE 100 Index climbed to its highest level since February 2020 as U.K. markets reopened after Christmas, catching up to European market gains, with the FTSE 100 Index rising to the highest level since February 2020. The FTSE 100 Index was up as much as 1% with Rolls-Royce the best performer with a 3% gain; the FTSE 250 Index gained as much as 1.3%; Darktrace jumps 5.1%. Technology shares declined, following the sector’s retreat in the U.S. and Asia. Volumes remained thin into the end of the year in some markets.

Earlier in the session, Asian stocks fell, led by losses in Chinese shares, amid an extended global selloff in technology giants. The MSCI Asia Pacific Index slid as much as 0.5%, with Samsung Electronics, Alibaba and Tencent among the biggest drags. China’s CSI 300 was the worst-performing major gauge in the region, losing 1.5%.

“There’s not much news, but the drop in Chinese shares has worsened the mood a bit,” said Tetsuo Seshimo, a fund manager at Saison Asset Management. “It’s almost strange how equity markets have been rising despite this sense of anticipated cutbacks in monetary easing by Europe and the U.S., so you’re seeing stocks correct recent gains.” U.S. stocks fell for the first time in five days amid a rotation out of megacap tech shares. While some traders saw a chance to take profits after the S&P 500 posted its 69th record-high close for 2021 on Monday, the market also remains wary over record numbers of daily Covid-19 cases. “I think the most pressing issue is omicron and whether or not surging case numbers lead to a pick-up in hospitalizations and fatalities in coming weeks,” said Kyle Rodda, a market analyst at IG Markets. “That could pull the rug from under the market, especially as trading conditions return to normal from next week onwards.” 

Japanese equities also slid as investors sold technology shares, mirroring moves in the U.S. market overnight. Electronics makers were the biggest drag on the Topix, which fell 0.3%. Tokyo Electron and Fast Retailing were the largest contributors to a 0.6% loss in the Nikkei 225.

India’s key stock gauges likewise fell after a two-day advance, led by declines in lenders. Dr. Reddy’s Laboratories and Sun Pharmaceutical rose after the government approved more vaccines and treatments to curb the spread of coronavirus.  The S&P BSE Sensex fell 0.2% to 57,806.49 in Mumbai, after swinging between gains and losses ahead of the expiry of monthly derivative contracts on Thursday. The NSE Nifty 50 Index slipped 0.1%. Twelve of the 19 sector sub-gauges compiled by BSE Ltd. fell, led by a measure of metals companies.   The government on Tuesday granted approval for restricted emergency use of two new vaccines and the anti-viral drug Molnupiravir, to be manufactured by local firms including Dr. Reddy’s. India recorded 9,195 new Covid-19 cases, according to the latest data release on Wednesday. The daily count surged from 6,358 on Tuesday. Rising infections have prompted some Indian states to impose curbs on public gatherings, with New Delhi ordering closures of cinemas, schools and gyms.  HDFC Bank contributed the most to the Sensex’s decline, falling 0.5%. Out of 30 shares in the benchmark, 18 fell and 12 rose.

In rates, Treasuries slipped in light trading as equity futures hold near Tuesday’s record high, with the year's last auction - a sale of $56 billion in 7-year paper due at 1pm ET, in low-volume trading typical of the last week of the year. Yields are higher cheaper by 1bp-2bp in 10- to 30-year sectors with front-end and belly yields little changed; 30-year at 1.917% is above its above its 50-DMA, breached Tuesday for first time since late November. Monday’s 2-year and Tuesday’s 5-year auctions tailed slightly, though both have since improved and sported solid internals. The WI 7Y yield ~1.42% is between last two auction stops and ~16bp richer than last month’s. Euro-area sovereign bonds were mixed, with German bunds fluctuating. Japanese government bonds gained as concern over the coronavirus omicron strain supports demand for haven assets.

In FX, a gauge of the U.S. dollar rose for a third day, sending the Japanese yen sliding past 115/USD for the first time in a month. The Turkish lira resumed its collapse, dropping as much as 5% against the dollar, extending this week’s loss to 15% with the nation’s 10-year government bond yield standing at an all-time high. Turkey’s central bank will prioritize the promotion of lira deposits next year after President Recep Tayyip Erdogan announced controversial new steps to curb the currency’s depreciation. Meanwhile, China’s overnight interbank borrowing rates plummet to the lowest level in 11 months after the central bank injected more liquidity into the financial system.

In commodities, crude oil hovered near a one-month high, partly on bets that the global recovery can ride out omicron. Iron ore futures in Singapore and China declined for a third day. Bitcoin stayed below $48,000 after a tumble that hinted at diminished ardor for the most speculative assets; the cryptocurrency remains on course for its biggest monthly drop since the cryptocurrency rout in May.

Market Snapshot

  • S&P 500 futures up 0.2% to 4,788.25
  • STOXX Europe 600 up 0.2% to 489.63
  • MXAP down 0.4% to 192.40
  • MXAPJ down 0.3% to 625.02
  • Nikkei down 0.6% to 28,906.88
  • Topix down 0.3% to 1,998.99
  • Hang Seng Index down 0.8% to 23,086.54
  • Shanghai Composite down 0.9% to 3,597.00
  • Sensex little changed at 57,920.29
  • Australia S&P/ASX 200 up 1.2% to 7,509.81
  • Kospi down 0.9% to 2,993.29
  • Brent Futures little changed at $78.95/bbl
  • Gold spot down 0.1% to $1,803.78
  • U.S. Dollar Index up 0.17% to 96.37
  • German 10Y yield little changed at -0.23%
  • Euro down 0.3% to $1.1279

Top Overnight News from Bloomberg

  • Investors are primed for the dollar to climb next year. But the juiciest trades may be over even before 2021 ends
  • The Bloomberg Dollar Index is racing toward its best annual gain in six years and hedge funds’ net long bets on the currency have climbed to the highest since June 2019 as traders have been front-running a hawkish Federal Reserve
  • European equities climbed toward a record in thin holiday trading as investors bet that the economic recovery can withstand the impact of the omicron variant
  • Bitcoin edged higher after a steep decline in choppy year-end trading, but it’s still on course for its biggest monthly drop since the cryptocurrency rout in May
  • U.K. households are heading into the “year of the squeeze” as surging energy bills and faster inflation eat into incomes, according to the Resolution Foundation think tank

US Event Calendar

  • 8:30am: Nov. Advance Goods Trade Balance, est. -$88.1b, prior - $82.9b
  • 8:30am: Nov. Retail Inventories MoM, est. 0.5%, prior 0.1%; Wholesale Inventories MoM, est. 1.5%, prior 2.3%
  • 10am: Nov. Pending Home Sales YoY, prior -4.7%; Pending Home Sales (MoM), est. 0.8%, prior 7.5%
Tyler Durden Wed, 12/29/2021 - 08:11

Read More

Continue Reading

Government

Low Iron Levels In Blood Could Trigger Long COVID: Study

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate…

Published

on

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate iron levels in their blood due to a COVID-19 infection could be at greater risk of long COVID.

(Shutterstock)

A new study indicates that problems with iron levels in the bloodstream likely trigger chronic inflammation and other conditions associated with the post-COVID phenomenon. The findings, published on March 1 in Nature Immunology, could offer new ways to treat or prevent the condition.

Long COVID Patients Have Low Iron Levels

Researchers at the University of Cambridge pinpointed low iron as a potential link to long-COVID symptoms thanks to a study they initiated shortly after the start of the pandemic. They recruited people who tested positive for the virus to provide blood samples for analysis over a year, which allowed the researchers to look for post-infection changes in the blood. The researchers looked at 214 samples and found that 45 percent of patients reported symptoms of long COVID that lasted between three and 10 months.

In analyzing the blood samples, the research team noticed that people experiencing long COVID had low iron levels, contributing to anemia and low red blood cell production, just two weeks after they were diagnosed with COVID-19. This was true for patients regardless of age, sex, or the initial severity of their infection.

According to one of the study co-authors, the removal of iron from the bloodstream is a natural process and defense mechanism of the body.

But it can jeopardize a person’s recovery.

When the body has an infection, it responds by removing iron from the bloodstream. This protects us from potentially lethal bacteria that capture the iron in the bloodstream and grow rapidly. It’s an evolutionary response that redistributes iron in the body, and the blood plasma becomes an iron desert,” University of Oxford professor Hal Drakesmith said in a press release. “However, if this goes on for a long time, there is less iron for red blood cells, so oxygen is transported less efficiently affecting metabolism and energy production, and for white blood cells, which need iron to work properly. The protective mechanism ends up becoming a problem.”

The research team believes that consistently low iron levels could explain why individuals with long COVID continue to experience fatigue and difficulty exercising. As such, the researchers suggested iron supplementation to help regulate and prevent the often debilitating symptoms associated with long COVID.

It isn’t necessarily the case that individuals don’t have enough iron in their body, it’s just that it’s trapped in the wrong place,” Aimee Hanson, a postdoctoral researcher at the University of Cambridge who worked on the study, said in the press release. “What we need is a way to remobilize the iron and pull it back into the bloodstream, where it becomes more useful to the red blood cells.”

The research team pointed out that iron supplementation isn’t always straightforward. Achieving the right level of iron varies from person to person. Too much iron can cause stomach issues, ranging from constipation, nausea, and abdominal pain to gastritis and gastric lesions.

1 in 5 Still Affected by Long COVID

COVID-19 has affected nearly 40 percent of Americans, with one in five of those still suffering from symptoms of long COVID, according to the U.S. Centers for Disease Control and Prevention (CDC). Long COVID is marked by health issues that continue at least four weeks after an individual was initially diagnosed with COVID-19. Symptoms can last for days, weeks, months, or years and may include fatigue, cough or chest pain, headache, brain fog, depression or anxiety, digestive issues, and joint or muscle pain.

Tyler Durden Sat, 03/09/2024 - 12:50

Read More

Continue Reading

Uncategorized

February Employment Situation

By Paul Gomme and Peter Rupert The establishment data from the BLS showed a 275,000 increase in payroll employment for February, outpacing the 230,000…

Published

on

By Paul Gomme and Peter Rupert

The establishment data from the BLS showed a 275,000 increase in payroll employment for February, outpacing the 230,000 average over the previous 12 months. The payroll data for January and December were revised down by a total of 167,000. The private sector added 223,000 new jobs, the largest gain since May of last year.

Temporary help services employment continues a steep decline after a sharp post-pandemic rise.

Average hours of work increased from 34.2 to 34.3. The increase, along with the 223,000 private employment increase led to a hefty increase in total hours of 5.6% at an annualized rate, also the largest increase since May of last year.

The establishment report, once again, beat “expectations;” the WSJ survey of economists was 198,000. Other than the downward revisions, mentioned above, another bit of negative news was a smallish increase in wage growth, from $34.52 to $34.57.

The household survey shows that the labor force increased 150,000, a drop in employment of 184,000 and an increase in the number of unemployed persons of 334,000. The labor force participation rate held steady at 62.5, the employment to population ratio decreased from 60.2 to 60.1 and the unemployment rate increased from 3.66 to 3.86. Remember that the unemployment rate is the number of unemployed relative to the labor force (the number employed plus the number unemployed). Consequently, the unemployment rate can go up if the number of unemployed rises holding fixed the labor force, or if the labor force shrinks holding the number unemployed unchanged. An increase in the unemployment rate is not necessarily a bad thing: it may reflect a strong labor market drawing “marginally attached” individuals from outside the labor force. Indeed, there was a 96,000 decline in those workers.

Earlier in the week, the BLS announced JOLTS (Job Openings and Labor Turnover Survey) data for January. There isn’t much to report here as the job openings changed little at 8.9 million, the number of hires and total separations were little changed at 5.7 million and 5.3 million, respectively.

As has been the case for the last couple of years, the number of job openings remains higher than the number of unemployed persons.

Also earlier in the week the BLS announced that productivity increased 3.2% in the 4th quarter with output rising 3.5% and hours of work rising 0.3%.

The bottom line is that the labor market continues its surprisingly (to some) strong performance, once again proving stronger than many had expected. This strength makes it difficult to justify any interest rate cuts soon, particularly given the recent inflation spike.

Read More

Continue Reading

Spread & Containment

Another beloved brewery files Chapter 11 bankruptcy

The beer industry has been devastated by covid, changing tastes, and maybe fallout from the Bud Light scandal.

Published

on

Before the covid pandemic, craft beer was having a moment. Most cities had multiple breweries and taprooms with some having so many that people put together the brewery version of a pub crawl.

It was a period where beer snobbery ruled the day and it was not uncommon to hear bar patrons discuss the makeup of the beer the beer they were drinking. This boom period always seemed destined for failure, or at least a retraction as many markets seemed to have more craft breweries than they could support.

Related: Fast-food chain closes more stores after Chapter 11 bankruptcy

The pandemic, however, hastened that downfall. Many of these local and regional craft breweries counted on in-person sales to drive their business. 

And while many had local and regional distribution, selling through a third party comes with much lower margins. Direct sales drove their business and the pandemic forced many breweries to shut down their taprooms during the period where social distancing rules were in effect.

During those months the breweries still had rent and employees to pay while little money was coming in. That led to a number of popular beermakers including San Francisco's nationally-known Anchor Brewing as well as many regional favorites including Chicago’s Metropolitan Brewing, New Jersey’s Flying Fish, Denver’s Joyride Brewing, Tampa’s Zydeco Brew Werks, and Cleveland’s Terrestrial Brewing filing bankruptcy.

Some of these brands hope to survive, but others, including Anchor Brewing, fell into Chapter 7 liquidation. Now, another domino has fallen as a popular regional brewery has filed for Chapter 11 bankruptcy protection.

Overall beer sales have fallen.

Image source: Shutterstock

Covid is not the only reason for brewery bankruptcies

While covid deserves some of the blame for brewery failures, it's not the only reason why so many have filed for bankruptcy protection. Overall beer sales have fallen driven by younger people embracing non-alcoholic cocktails, and the rise in popularity of non-beer alcoholic offerings,

Beer sales have fallen to their lowest levels since 1999 and some industry analysts

"Sales declined by more than 5% in the first nine months of the year, dragged down not only by the backlash and boycotts against Anheuser-Busch-owned Bud Light but the changing habits of younger drinkers," according to data from Beer Marketer’s Insights published by the New York Post.

Bud Light parent Anheuser Busch InBev (BUD) faced massive boycotts after it partnered with transgender social media influencer Dylan Mulvaney. It was a very small partnership but it led to a right-wing backlash spurred on by Kid Rock, who posted a video on social media where he chastised the company before shooting up cases of Bud Light with an automatic weapon.

Another brewery files Chapter 11 bankruptcy

Gizmo Brew Works, which does business under the name Roth Brewing Company LLC, filed for Chapter 11 bankruptcy protection on March 8. In its filing, the company checked the box that indicates that its debts are less than $7.5 million and it chooses to proceed under Subchapter V of Chapter 11. 

"Both small business and subchapter V cases are treated differently than a traditional chapter 11 case primarily due to accelerated deadlines and the speed with which the plan is confirmed," USCourts.gov explained. 

Roth Brewing/Gizmo Brew Works shared that it has 50-99 creditors and assets $100,000 and $500,000. The filing noted that the company does expect to have funds available for unsecured creditors. 

The popular brewery operates three taprooms and sells its beer to go at those locations.

"Join us at Gizmo Brew Works Craft Brewery and Taprooms located in Raleigh, Durham, and Chapel Hill, North Carolina. Find us for entertainment, live music, food trucks, beer specials, and most importantly, great-tasting craft beer by Gizmo Brew Works," the company shared on its website.

The company estimates that it has between $1 and $10 million in liabilities (a broad range as the bankruptcy form does not provide a space to be more specific).

Gizmo Brew Works/Roth Brewing did not share a reorganization or funding plan in its bankruptcy filing. An email request for comment sent through the company's contact page was not immediately returned.

 

Read More

Continue Reading

Trending